Targeting EBV Episome for Anti-Cancer Therapy: Emerging Strategies and Challenges
As a ubiquitous human pathogen, the Epstein–Barr virus (EBV) has established lifelong persistent infection in about 95% of the adult population. The EBV infection is associated with approximately 200,000 human cancer cases and 140,000 deaths per year. The presence of EBV in tumor cells provides a un...
Saved in:
| Main Authors: | Febri Gunawan Sugiokto, Renfeng Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Viruses |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4915/17/1/110 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
基于episomal CRISPR/Cas9 载体的基因敲入方法
by: 邹征伟, et al.
Published: (2018-01-01) -
Immunological Prevalence of EBV in Rheumatoid Arthritis Iraqi Patients
by: Wafaa Ayad Al-Nuaimy, et al.
Published: (2025-07-01) -
In silico Approach of Some Selected Manuka Honey Constituents as Epstein–Barr Virus (EBV) Nuclear Antigen 1 (EBNA1) Inhibitors
by: Achmad Chusnu Romdhoni, et al.
Published: (2023-12-01) -
Active EBV infection in children: associations between DNA load, infection status, immune status, and disease severity
by: Haipeng Yan, et al.
Published: (2025-04-01) -
The role of EBV lytic genes in tumor development and progression
by: DENG Yizhang, et al.
Published: (2024-09-01)